Internet-Based Cognitive Behavioral Therapy for Insomnia and Mild Cognitive Impairment
Trial Summary
The trial requires that participants have a stable medication regimen unless the medication is known to cause insomnia. If your current medication is stable and not causing insomnia, you likely won't need to stop taking it.
Research shows that Internet-based cognitive-behavioral therapy for insomnia (CBT-I), like SHUTi, is effective in improving sleep quality and reducing insomnia symptoms. Studies have found it to be convenient, understandable, and useful, with most users experiencing improved sleep and quality of life.
12345The studies on Internet-Based Cognitive Behavioral Therapy for Insomnia, such as SHUTi, suggest that it is generally safe for humans. Participants in these studies reported positive experiences and improvements in sleep without any significant safety concerns.
34567SHUTi OASIS is unique because it is an internet-based cognitive behavioral therapy specifically designed for older adults with insomnia and mild cognitive impairment, offering a convenient and accessible option compared to traditional in-person therapy sessions.
3891011Eligibility Criteria
This trial is for US residents aged 65 or older with mild cognitive impairment and insomnia, who can read English and have internet access. They must be willing to follow the study procedures for its duration. Excluded are those with irregular sleep schedules, substance abuse issues, severe depression risk, recent psychological treatments, certain medical conditions like untreated sleep disorders or epilepsy without stable treatment.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Pre-assessment
Participants complete an online cognitive test, an online questionnaire, and two weeks of sleep diaries
Treatment
Participants receive either the Internet-based CBT-I intervention or patient education for 9 weeks
Post-assessment
Participants complete the post-assessment battery including cognitive test, questionnaires, and diaries
Follow-up
Participants are monitored for changes in sleep, cognitive status, and other health measures at 6, 12, 18, and 24 months
Participant Groups
SHUTi OASIS is already approved in United States for the following indications:
- Insomnia
- Mild Cognitive Impairment